UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 06/2020, Volume 382, Issue 25, pp. e102 - 2464
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiac arrhythmia | Arrhythmia | Laboratories | Cardiovascular disease | Beta blockers | Data dictionaries | COVID-19 | Confidence intervals | Variables | Chronic obstructive pulmonary disease | Cardiology | Drug therapy | Heart diseases | Age | Heart failure | Hypertension | Automation | Mortality | Lung diseases | Coronary artery | Regression analysis | Coronaviruses | Patients | Hospitals | Collaboration | Coronary vessels | Obstructive lung disease | Angiotensin | Death | Software | Diabetes | Cardiovascular diseases | Electronic health records | Index Medicus | Abridged Index Medicus
Journal Article
Nature reviews. Drug discovery, ISSN 1474-1776, 03/2020, Volume 19, Issue 3, pp. 149 - 150
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Betacoronavirus - pathogenicity | Recombinant Proteins - therapeutic use | Interferon-alpha - pharmacology | Alanine - therapeutic use | Hepatitis C - drug therapy | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Polyethylene Glycols - therapeutic use | COVID-19 | Alanine - analogs & derivatives | Protease Inhibitors - pharmacology | SARS-CoV-2 | SARS Virus - genetics | Nucleosides - pharmacology | Spike Glycoprotein, Coronavirus - drug effects | Influenza, Human - drug therapy | Protease Inhibitors - therapeutic use | Polyethylene Glycols - pharmacology | Nucleosides - therapeutic use | Antiviral Agents - therapeutic use | Betacoronavirus - drug effects | Interferon-alpha - therapeutic use | Middle East Respiratory Syndrome Coronavirus - drug effects | SARS Virus - drug effects | Drug Repositioning | Recombinant Proteins - pharmacology | Adenosine Monophosphate - therapeutic use | SARS Virus - pathogenicity | Middle East Respiratory Syndrome Coronavirus - pathogenicity | Middle East Respiratory Syndrome Coronavirus - genetics | Adenosine Monophosphate - analogs & derivatives | Hepatitis B - drug therapy | HIV Infections - drug therapy | Betacoronavirus - genetics | Antiviral agents | Pharmacology, Experimental | Physiological aspects | Drug targeting | Genetic aspects | Research | Coronaviruses | Clinical trials | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 07/2020, Volume 583, Issue 7816, pp. 469 - 472
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Pandemics | Proteostasis | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Betacoronavirus - growth & development | Host-Pathogen Interactions - drug effects | Molecular Targeted Therapy | COVID-19 | Pneumonia, Viral - metabolism | RNA Splicing | SARS-CoV-2 | Coronavirus Infections - metabolism | Pneumonia, Viral - genetics | Time Factors | Drug Evaluation, Preclinical | Caco-2 Cells | Carbon - metabolism | Virus Replication - drug effects | Betacoronavirus - drug effects | Coronavirus Infections - genetics | Betacoronavirus - metabolism | Coronavirus Infections - virology | Host-Pathogen Interactions - genetics | Proteomics | Protein Biosynthesis - drug effects | Kinetics | In Vitro Techniques | Betacoronavirus - genetics | Pneumonia, Viral - virology | Proteome - metabolism | Drug targeting | Coronaviruses | Research | Host-virus relationships | Health aspects | Methods | Cell culture | Splicing | Health services | Severe acute respiratory syndrome | Viral diseases | Homeostasis | Principal components analysis | Viruses | Infections | Nucleic acids | Metabolism | Carbon | Protein turnover | Severe acute respiratory syndrome coronavirus 2 | Proteins | Molecular modelling | Disease transmission | Pathways | Respiratory diseases | Replication | Viral infections | Index Medicus
Journal Article
Journal of medical virology, ISSN 0146-6615, 07/2020, Volume 92, Issue 7, pp. 797 - 806
northeast Chongqing | treatment | cognition | COVID‐19 | clinical features | Life Sciences & Biomedicine | Science & Technology | Virology | Betacoronavirus - pathogenicity | Diabetes Mellitus - pathology | Cough - physiopathology | Coronavirus Infections - drug therapy | Humans | Middle Aged | Pneumonia, Viral - drug therapy | Male | Tomography, X-Ray Computed | Interferons - therapeutic use | Neoplasms - diagnosis | Adrenal Cortex Hormones - therapeutic use | Fever - physiopathology | COVID-19 | Cardiovascular Diseases - complications | SARS-CoV-2 | Ritonavir - therapeutic use | Cardiovascular Diseases - diagnosis | Betacoronavirus - isolation & purification | Antiviral Agents - therapeutic use | Diabetes Mellitus - drug therapy | Diabetes Complications - drug therapy | Fatigue - diagnosis | Biomarkers - blood | Diabetes Complications - blood | Fever - virology | Neoplasms - drug therapy | Adolescent | Coronavirus Infections - pathology | Fatigue - physiopathology | Fatigue - virology | Pneumonia, Viral - diagnosis | Pandemics | COVID-19 Testing | Cardiovascular Diseases - drug therapy | Cough - diagnosis | Cardiovascular Diseases - pathology | Anti-Bacterial Agents - therapeutic use | Neoplasms - complications | China | Pneumonia, Viral - complications | Coronavirus Infections - complications | Adult | Female | Retrospective Studies | Diabetes Mellitus - diagnosis | Drugs, Chinese Herbal - therapeutic use | Severity of Illness Index | Cough - virology | Coronavirus Infections - diagnosis | Pneumonia, Viral - pathology | Fever - diagnosis | Clinical Laboratory Techniques - methods | Lopinavir - therapeutic use | Aged | Neoplasms - pathology | Drug Combinations | Corticoids | Therapy | Anorexia | Health services | Viral diseases | Malignancy | Gender | Epidemiology | Antiinfectives and antibacterials | Chinese medicine | Dyspnea | Computed tomography | Lymphocytes | Opacity | Public health | Hypertension | Signs and symptoms | Corticosteroids | Complications | Diabetes mellitus | Health risks | Traditional Chinese medicine | Fatigue | Lactate dehydrogenase | Myalgia | Coronaviruses | Patients | Fever | Cough | L-Lactate dehydrogenase | Herbal medicine | Infectious diseases | Respiratory distress syndrome | Cell number | Secondary infection | Interferon | Aspartate aminotransferase | Plasma levels | Dimers | Lactic acid | Cardiovascular diseases | Respiration | Index Medicus
Journal Article
Journal of medical virology, ISSN 0146-6615, 06/2020, Volume 92, Issue 6, pp. 556 - 563
coronavirus | SARS | COVID‐19 | lopinavir | MERS | Life Sciences & Biomedicine | Science & Technology | Virology | Betacoronavirus - pathogenicity | Severe Acute Respiratory Syndrome - epidemiology | Pandemics | Severe Acute Respiratory Syndrome - virology | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Betacoronavirus - enzymology | Severe Acute Respiratory Syndrome - diagnosis | COVID-19 | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Middle East Respiratory Syndrome Coronavirus - enzymology | Ritonavir - therapeutic use | Disease Models, Animal | Cell Line | Antiviral Agents - therapeutic use | Coronavirus Infections - diagnosis | Betacoronavirus - drug effects | Middle East Respiratory Syndrome Coronavirus - drug effects | SARS Virus - drug effects | Treatment Outcome | Clinical Trials as Topic | Severe Acute Respiratory Syndrome - drug therapy | SARS Virus - pathogenicity | Middle East Respiratory Syndrome Coronavirus - pathogenicity | Animals | Coronavirus Infections - virology | Pneumonia, Viral - diagnosis | Lopinavir - therapeutic use | Mice | Pneumonia, Viral - virology | SARS Virus - enzymology | Epidemics | Health services | Therapeutic applications | Severe acute respiratory syndrome | Medical treatment | Lopinavir | Viral diseases | Health risks | Coronaviruses | Middle East respiratory syndrome | Literature reviews | Respiratory diseases | Public health | Index Medicus | Reviews | Review
Journal Article
Nature (London), ISSN 0028-0836, 07/2020, Volume 583, Issue 7816, pp. 459 - 468
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Betacoronavirus - pathogenicity | Pandemics | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Host-Pathogen Interactions - drug effects | Molecular Targeted Therapy | Viral Proteins - metabolism | Protein Interaction Maps | COVID-19 | Pneumonia, Viral - metabolism | SARS-CoV-2 | Antiviral Agents - classification | Coronavirus Infections - metabolism | Mass Spectrometry | Cloning, Molecular | HEK293 Cells | Protein Domains | Drug Evaluation, Preclinical | Receptors, sigma - metabolism | Vero Cells | Antiviral Agents - pharmacology | Chlorocebus aethiops | Betacoronavirus - drug effects | Viral Proteins - genetics | SKP Cullin F-Box Protein Ligases - metabolism | Drug Repositioning | Betacoronavirus - metabolism | Immunity, Innate | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Protein Interaction Mapping | Animals | Coronavirus Infections - virology | Protein Binding | Protein Biosynthesis - drug effects | Betacoronavirus - genetics | Pneumonia, Viral - virology | Protein research | Drug targeting | Genetic aspects | Coronaviruses | Research | Health aspects | Methods | Interactomes | Drugs | Regulators | Laboratories | Protein purification | Viral diseases | Clinical trials | Infections | Genomes | mRNA | Vaccines | Middle East respiratory syndrome | Proteins | Antiviral activity | Antiviral agents | Enzymes | Severe acute respiratory syndrome | Cloning | Mass spectroscopy | RNA polymerase | Gene expression | Severe acute respiratory syndrome coronavirus 2 | Respiratory diseases | Fatalities | Scientific imaging | Protein interaction | Mass spectrometry | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 12/2020, Volume 71, Issue 9, pp. 2459 - 2468
antimicrobial stewardship | antimicrobial resistance | SARS-CoV-2 | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Mycoses - epidemiology | Antimicrobial Stewardship | Bacterial Infections - drug therapy | Coinfection - drug therapy | Humans | Anti-Infective Agents - therapeutic use | Mycoses - microbiology | Coinfection - epidemiology | COVID-19 - drug therapy | Drug Resistance, Microbial | Coinfection - microbiology | COVID-19 - microbiology | Bacterial Infections - epidemiology | Mycoses - drug therapy | SARS-CoV-2 - drug effects | COVID-19 - epidemiology | Bacterial Infections - microbiology | Index Medicus
Journal Article
BioFactors (Oxford), ISSN 0951-6433, 01/2021, Volume 47, Issue 1, pp. 6 - 18
acute respiratory distress syndrome | COVID‐19 | lung injury | specialized proresolving mediators | inflammation resolution | COVID-19 | Biochemistry & Molecular Biology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Lung Injury - pathology | Tuberculosis, Pulmonary - metabolism | Influenza, Human - pathology | Humans | Pulmonary Disease, Chronic Obstructive - virology | Tuberculosis, Pulmonary - drug therapy | Pulmonary Disease, Chronic Obstructive - pathology | Herpes Simplex - drug therapy | Periodontitis - metabolism | Sepsis - drug therapy | Lung Injury - virology | Respiratory Distress Syndrome - virology | Sepsis - pathology | COVID-19 - metabolism | Lipoxins - therapeutic use | Sepsis - metabolism | Lung Injury - metabolism | Anti-Inflammatory Agents - therapeutic use | Respiratory Distress Syndrome - drug therapy | Lung - metabolism | Influenza, Human - drug therapy | Lung Injury - drug therapy | Pulmonary Disease, Chronic Obstructive - metabolism | Docosahexaenoic Acids - therapeutic use | COVID-19 - virology | Influenza, Human - metabolism | Lung - pathology | Periodontitis - pathology | Tuberculosis, Pulmonary - pathology | COVID-19 - drug therapy | Herpes Simplex - metabolism | Respiratory Distress Syndrome - pathology | Periodontitis - drug therapy | SARS-CoV-2 - pathogenicity | Herpes Simplex - pathology | Lung - drug effects | Respiratory Distress Syndrome - metabolism | COVID-19 - pathology | Pulmonary Disease, Chronic Obstructive - drug therapy | Index Medicus
Journal Article